Cargando…
Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial
PURPOSE: To compare the outcomes of photodynamic therapy (PDT) combined with intravitreal bevacizumab (IVB) with versus without intravitreal triamcinolone (IVT) in neovascular age-related macular degeneration (AMD). METHODS: Eighty-four eyes with active CNV secondary to AMD with no prior treatment w...
Autores principales: | Piri, Niloofar, Ahmadieh, Hamid, Taei, Ramin, Soheilian, Masoud, Karkhaneh, Reza, Lashay, Alireza, Golbafian, Faegheh, Yaseri, Mehdi, Riazi-Esfahani, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329708/ https://www.ncbi.nlm.nih.gov/pubmed/25709773 http://dx.doi.org/10.4103/2008-322X.150826 |
Ejemplares similares
-
Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
por: Ahmadieh, Hamid, et al.
Publicado: (2007) -
Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
por: Riazi-Esfahani, Mohammad, et al.
Publicado: (2008) -
Intravitreal Bevacizumab with or without Triamcinolone for Refractory Diabetic Macular Edema: Long-term Results of a Clinical Trial
por: Shoeibi, Nasser, et al.
Publicado: (2013) -
Intravitreal Medications for Retinal Vein Occlusion: Systematic Review and Meta-analysis
por: Lashay, Alireza, et al.
Publicado: (2019) -
Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Non-Age-Related Macular Degeneration
por: Salehipour, Masoud, et al.
Publicado: (2010)